EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Myo-inositol versus metformin pre-treatment and the follicular-fluid metabolome in PCOS women undergoing IVF: a double-blind randomized trial

Syaifudin, Dessy Agustina, Sarah Istiqomah

Sriwijaya Journal of Obstetrics and Gynecology · 21.07.2026 · 4 (1) · 17-24

DOI: 10.59345/sjog.v4i1.299 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sriwijaya Journal of Obstetrics and Gynecology, online erschienen am 21.07.2026. Verfasst von Syaifudin und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome (PCOS) impairs oocyte quality and complicates in vitro fertilization (IVF). Metformin and myo-inositol are widely prescribed insulin sensitizers, yet their comparative effects on the human follicular-fluid (FF) metabolome and IVF outcomes have rarely been examined head-to-head.

Objective

To compare myo-inositol and metformin pre-treatment in terms of the FF metabolome and embryologic, clinical, and safety outcomes in women with PCOS undergoing IVF.

Methods

In a double-blind, block-randomized (1:1) trial at two tertiary IVF centers in Jakarta and Palembang, Indonesia, 150 women with PCOS (Rotterdam criteria; aged 20–35 years; BMI 18.5–29.9 kg/m²) received myo-inositol 4 g/day (n=75) or metformin 1500 mg/day (n=75) for 12 weeks before and during a GnRH-antagonist protocol. FF was analyzed by LC-MS/MS. Analyses were intention-to-treat and included multivariable logistic regression, ROC analysis, and number needed to treat (NNT).

Results

Myo-inositol yielded more MII oocytes (11.6 ± 3.4 vs 10.1 ± 3.6; p=0.010), higher fertilization (72.5% vs 66.8%; p=0.006), and more top-quality embryos (4.3 ± 1.8 vs 3.4 ± 1.7; p=0.002). Clinical pregnancy was 48.0% versus 33.3% (unadjusted p=0.069; adjusted OR 2.18, 95% CI 1.04–4.57; p=0.039; NNT 7). Moderate–severe OHSS (6.7% vs 18.7%; p=0.038; NNT 8) and gastrointestinal events (9.3% vs 34.7%; p

Zitieren

APA

Syaifudin, Agustina, D., & Istiqomah, S. (2026). Myo-inositol versus metformin pre-treatment and the follicular-fluid metabolome in PCOS women undergoing IVF: a double-blind randomized trial. Sriwijaya Journal of Obstetrics and Gynecology, 4(1), 17-24. https://doi.org/10.59345/sjog.v4i1.299

Vancouver

Syaifudin, Agustina D, Istiqomah S. Myo-inositol versus metformin pre-treatment and the follicular-fluid metabolome in PCOS women undergoing IVF: a double-blind randomized trial. Sriwijaya Journal of Obstetrics and Gynecology. 2026;4(1):17-24. doi:10.59345/sjog.v4i1.299

BibTeX
@article{Syaifudin2026,
  author = {Syaifudin and Agustina, Dessy and Istiqomah, Sarah},
  title = {Myo-inositol versus metformin pre-treatment and the follicular-fluid metabolome in PCOS women undergoing IVF: a double-blind randomized trial},
  journal = {Sriwijaya Journal of Obstetrics and Gynecology},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {17--24},
  doi = {10.59345/sjog.v4i1.299}
}
Kostenlos starten →